主要文件

查看所有文档

A79000

4-氨基喹哪啶

Name: 4-氨基喹哪啶
Brand: ALDRICH

98%

别名:

4-氨基-2-甲基喹啉

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₁₀H₁₀N₂

化学文摘社编号:

6628-04-2

分子量:

158.20

UNSPSC Code:

12352100

NACRES:

NA.22

PubChem Substance ID:

24891290

EC Number:

229-604-4

Beilstein/REAXYS Number:

118323

MDL number:

MFCD00006759

Assay:

98%

Form:

powder

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

Quality Level

100

assay

98%

form

powder

bp

333 °C (lit.)

mp

162-166 °C (lit.)

SMILES string

Cc1cc(N)c2ccccc2n1

InChI

1S/C10H10N2/c1-7-6-9(11)8-4-2-3-5-10(8)12-7/h2-6H,1H3,(H2,11,12)

InChI key

COCFIBRMFPWUDW-UHFFFAOYSA-N

说明

Still not finding the right product?

Explore all of our products under 4-氨基喹哪啶

pictograms

GHS07

signalword

Warning

hcodes

H315,H319,H335

pcodes

P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Synthesis and characterizations of novel quinoline derivatives having mixed ligand activities at the kappa and mu receptors: Potential therapeutic efficacy against morphine dependence.

Ishani Deb et al.

Bioorganic & medicinal chemistry, 17(16), 5782-5790 (2009-07-31)

Based on an established 3D pharmacophore, a series of quinoline derivatives were synthesized. The opioidergic properties of these compounds were determined by a competitive binding assay using (125)I-Dynorphine, (3)H-DAMGO and (125)I-DADLE for kappa, mu, and delta receptors, respectively. Results showed

Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase.

Stefania Ferrari et al.

Journal of medicinal chemistry, 54(1), 211-221 (2010-12-04)

Folate analogue inhibitors of Leishmania major pteridine reductase (PTR1) are potential antiparasitic drug candidates for combined therapy with dihydrofolate reductase (DHFR) inhibitors. To identify new molecules with specificity for PTR1, we carried out a virtual screening of the Available Chemicals

全球贸易项目编号

货号	GTIN
A79000-25G	04061833324448
A79000-5G	04061833386590